229 related articles for article (PubMed ID: 21406335)
1. miRNA expression profiling of mycosis fungoides.
van Kester MS; Ballabio E; Benner MF; Chen XH; Saunders NJ; van der Fits L; van Doorn R; Vermeer MH; Willemze R; Tensen CP; Lawrie CH
Mol Oncol; 2011 Jun; 5(3):273-80. PubMed ID: 21406335
[TBL] [Abstract][Full Text] [Related]
2. Aberrant microRNA expression in tumor mycosis fungoides.
Papadavid E; Braoudaki M; Bourdakou M; Lykoudi A; Nikolaou V; Tounta G; Ekonomidi A; Athanasiadis E; Spyrou G; Antoniou C; Kitsiou-Tzeli S; Rigopoulos D; Kolialexi A
Tumour Biol; 2016 Nov; 37(11):14667-14675. PubMed ID: 27623940
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides.
Benner MF; Ballabio E; van Kester MS; Saunders NJ; Vermeer MH; Willemze R; Lawrie CH; Tensen CP
Exp Dermatol; 2012 Aug; 21(8):632-4. PubMed ID: 22776000
[TBL] [Abstract][Full Text] [Related]
4. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides progression could be regulated by microRNAs.
Manso R; Martínez-Magunacelaya N; Eraña-Tomás I; Monsalvez V; Rodríguez-Peralto JL; Ortiz-Romero PL; Santonja C; Cristóbal I; Piris MA; Rodríguez-Pinilla SM
PLoS One; 2018; 13(6):e0198477. PubMed ID: 29894486
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
7. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
[TBL] [Abstract][Full Text] [Related]
8. Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation.
Rittig AH; Johansen C; Celis P; Odum N; Litman T; Woetmann A; Lindahl LM; Iversen L
Exp Dermatol; 2021 Aug; 30(8):1141-1149. PubMed ID: 32492224
[TBL] [Abstract][Full Text] [Related]
9. Altered microRNA expression in folliculotropic and transformed mycosis fungoides.
Marosvári D; Téglási V; Csala I; Marschalkó M; Bödör C; Timár B; Csomor J; Hársing J; Reiniger L
Pathol Oncol Res; 2015 Jul; 21(3):821-5. PubMed ID: 25698383
[TBL] [Abstract][Full Text] [Related]
10. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study.
Lindahl LM; Besenbacher S; Rittig AH; Celis P; Willerslev-Olsen A; Gjerdrum LMR; Krejsgaard T; Johansen C; Litman T; Woetmann A; Odum N; Iversen L
Blood; 2018 Feb; 131(7):759-770. PubMed ID: 29208599
[TBL] [Abstract][Full Text] [Related]
11. miR-155 is involved in tumor progression of mycosis fungoides.
Moyal L; Barzilai A; Gorovitz B; Hirshberg A; Amariglio N; Jacob-Hirsch J; Maron L; Feinmesser M; Hodak E
Exp Dermatol; 2013 Jun; 22(6):431-3. PubMed ID: 23711069
[TBL] [Abstract][Full Text] [Related]
12. Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome.
van Doorn R; van Kester MS; Dijkman R; Vermeer MH; Mulder AA; Szuhai K; Knijnenburg J; Boer JM; Willemze R; Tensen CP
Blood; 2009 Jan; 113(1):127-36. PubMed ID: 18832135
[TBL] [Abstract][Full Text] [Related]
13. miRNA Signature in Early-stage Mycosis Fungoides.
Sørensen ST; Litman T; Gluud M; Celis P; Torres-Rusillo S; Willerslev-Olsen A; Ødum N; Iversen L; Lindahl LM
Acta Derm Venereol; 2022 Oct; 102():adv00785. PubMed ID: 35788691
[TBL] [Abstract][Full Text] [Related]
14. Stage-dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-associated Inflammatory Cells in Folliculotropic Mycosis Fungoides.
Atzmony L; Moyal L; Feinmesser M; Gorovitz B; Hirshberg A; Amitay-Laish I; Prag-Naveh H; Barzilai A; Hodak E
Acta Derm Venereol; 2020 Aug; 100(15):adv00230. PubMed ID: 32556361
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
16. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients.
Talaat IM; Abdelmaksoud RE; Guimei M; Agamia NF; Nugud A; El-Serafi AT
PLoS One; 2019; 14(10):e0224305. PubMed ID: 31648231
[TBL] [Abstract][Full Text] [Related]
17. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
Wood GS; Tung RM; Haeffner AC; Crooks CF; Liao S; Orozco R; Veelken H; Kadin ME; Koh H; Heald P
J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
[TBL] [Abstract][Full Text] [Related]
18. Unilesional mycosis fungoides is associated with increased expression of microRNA-17~92 and T helper 1 skewing.
Moyal L; Gorovitz-Haris B; Yehezkel S; Jacob-Hirsch J; Bershtein V; Barzilai A; Rotem C; Sherman S; Amitay-Laish I; Feinmesser M; Hodak E
Br J Dermatol; 2019 May; 180(5):1123-1134. PubMed ID: 30431147
[TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.
Ballabio E; Mitchell T; van Kester MS; Taylor S; Dunlop HM; Chi J; Tosi I; Vermeer MH; Tramonti D; Saunders NJ; Boultwood J; Wainscoat JS; Pezzella F; Whittaker SJ; Tensen CP; Hatton CS; Lawrie CH
Blood; 2010 Aug; 116(7):1105-13. PubMed ID: 20448109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
